Open Closing in a 7 days

NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide

Descriptions

NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

 

Periods of call-offs under the framework agreement:

CM/PHG/24/5716/01- Hospital Only Products - Lenalidomide

CESW: (Midlands and Southwest): 1st June 2026 - 31st May 2028

NWLN: (Northwest and London North): 1st June 2026 - 31st May 2028

LSNE: (London South and Northeast): 1st June 2026 - 31st May 2028

CM/PHG/24/5716/02 - Hospital Only Products - Pomalidomide

CESW: (Midlands and Southwest): 1st June 2026 - 31st May 2028

NWLN: (Northwest and London North): 1st June 2026 - 31st May 2028

LSNE: (London South and Northeast): 1st June 2026 - 31st May 2028

CM/PHG/24/5716/03 - Hospital Only Products - Thalidomide

CESW: (Midlands and Southwest): 1st June 2026 - 31st May 2028

NWLN: (Northwest and London North): 1st June 2026 - 31st May 2028

LSNE: (London South and Northeast): 1st June 2026 - 31st May 2028

Engagement

NHS England is advising suppliers of an upcoming tender for the NHS Generics Pharmaceuticals – Lenalidomide, Pomalidomide & Thalidomide to commence on 1st June 2026 for 24 months with options to extend for a maximum total contract period of 48 months. This procurement will consist Lenalidomide, Pomalidomide and Thalidomide products across all regions of the country. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ . Specific information regarding the products included in this procurement will be provided in the ITO which will be issued shortly.

Timeline

Published Date :

23rd Jan 2026 Today

Deadline :

30th Jan 2026 in a 7 days

Contract Start :

31st May 2026

Contract End :

31st May 2028

CPV Codes

Keywords

medicinal drugs

prescription medicines

pharmaceutical compounds

generic pharmaceuticals

active pharmaceutical ingredients

Tender Lot Details & Award Criteria

1 Tender Lots

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Open

Procedure :

N/A

Suitable for SME :

Yes

Nationwide :

No

Assign to :

Tender Progress :

0%

Details

Notice Type :

Framework

Tender Identifier :

IT-378-246-T: 2024 - 001

Tenderbase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Buyer Information

Name :

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement Contact

Name :

Tina Smith

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk